313 related articles for article (PubMed ID: 15109957)
1. Characterization of Epstein-Barr virus infection in a human signet ring cell gastric carcinoma cell line, HSC-39.
Luo B; Murakami M; Fukuda M; Fujioka A; Yanagihara K; Sairenji T
Microbes Infect; 2004 Apr; 6(5):429-39. PubMed ID: 15109957
[TBL] [Abstract][Full Text] [Related]
2. [CD21-independent infection of a human signet ring cell gastric carcinoma cell line by Epstein-Barr virus].
Luo B; Masanao M; Makoto F; Kazuoshi Y; Takeshi S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):59-61. PubMed ID: 15340529
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
4. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
5. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
6. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
9. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
[TBL] [Abstract][Full Text] [Related]
10. Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma.
Hoshikawa Y; Satoh Y; Murakami M; Maeta M; Kaibara N; Ito H; Kurata T; Sairenji T
J Med Virol; 2002 Mar; 66(3):351-9. PubMed ID: 11793387
[TBL] [Abstract][Full Text] [Related]
11. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
[TBL] [Abstract][Full Text] [Related]
12. A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer.
Oh ST; Seo JS; Moon UY; Kang KH; Shin DJ; Yoon SK; Kim WH; Park JG; Lee SK
Virology; 2004 Mar; 320(2):330-6. PubMed ID: 15016554
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
Peng R; Moses SC; Tan J; Kremmer E; Ling PD
J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
[TBL] [Abstract][Full Text] [Related]
14. Detection of the Epstein-Barr virus in primary adenocarcinoma of the lung with Signet-ring cells.
Huber M; Pavlova B; Mühlberger H; Hollaus P; Lintner F
Virchows Arch; 2002 Jul; 441(1):25-30. PubMed ID: 12111197
[TBL] [Abstract][Full Text] [Related]
15. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection in non-carcinomatous gastric epithelium.
Yanai H; Takada K; Shimizu N; Mizugaki Y; Tada M; Okita K
J Pathol; 1997 Nov; 183(3):293-8. PubMed ID: 9422984
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection in sarcomatoid renal cell carcinoma tissues.
Kim KH; Han EM; Lee ES; Park HS; Kim I; Kim YS
BJU Int; 2005 Sep; 96(4):547-52. PubMed ID: 16104908
[TBL] [Abstract][Full Text] [Related]
18. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
Schlager S; Speck SH; Woisetschläger M
J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
Komano J; Sugiura M; Takada K
J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]